(object) array( 'id' => '1467657', 'url' => 'SR/Lotronex', 'image' => '', 'title' => 'Lotronex', 'tags' => array ( 0 => 'Lotronex', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lotronex', 'source_id' => 31150, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'lek koji se koristi u lečenju sindroma iritabilnog kolona kod žena', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845763, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lotronex', 'Definition' => 'a prescription drug used to treat IBS in women', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lotronex', )

(object) array( 'id' => '1461318', 'url' => 'SR/price_ceiling', 'image' => '', 'title' => 'maksimalna cena', 'tags' => array ( 0 => 'maksimalna cena', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'maksimalna cena', 'source_id' => 54604, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Maksimalna cena može biti određena bilo zakonskim ili tržišnim uslovima.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862277, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'price ceiling', 'Definition' => 'The maximum the price can be set, whether by law or market conditions.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'price_ceiling', )

(object) array( 'id' => '1461319', 'url' => 'SR/price_floor', 'image' => '', 'title' => 'minimalna cena', 'tags' => array ( 0 => 'minimalna cena', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'minimalna cena', 'source_id' => 54607, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Minimalni iznos koji se moe naplatiti prema vrednosti proizvoda ili zakonskim restrikcijama.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862278, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'price floor', 'Definition' => 'The minimum amount that can be charged due to product cost or law restrictions.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'price_floor', )

(object) array( 'id' => '1461004', 'url' => 'SR/double-blind_study', 'image' => '', 'title' => 'duplo-slepa studija', 'tags' => array ( 0 => 'duplo-slepa studija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'duplo-slepa studija', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Klinička studija u kojoj ni pojedinci koji u njoj učestvuju ni stručna lica koja studiju sprovode ne znaju koji ispitanici dobijaju eksperimentalni lek a koji placebo(ili drugu terapiju). Smatra se da duplo-slepa studija daje objektivne rezultate, pošto očekivanja lekara i ispitanika vezana za eksperimentalni lek ne utiču negativno na sam ishod:poznata još pod nazivom duplo-maskirana studija. Vidi slepa-studija,jednostruko-slepa studija i placebo', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907778, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '1461049', 'url' => 'SR/phase_iii_trials', 'image' => '', 'title' => 'Treća faza ispitivanja', 'tags' => array ( 0 => 'Treća faza ispitivanja', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Treća faza ispitivanja', 'source_id' => 30918, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705155511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Proširena kontrolisana i nekontrolisana ispitivanja posle preliminarne evidencije kojom je postignuta efikasnost leka i kojom se namerava prikupljanje dodatnih informacija za procenu sveukupnog odnosa korist-rizik leka i omogući adekvatna osnova za lekara opšte prakse.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966432247812, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'phase iii trials', 'Definition' => 'Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug and provide and adequate basis for physician labeling.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'phase_iii_trials', )

(object) array( 'id' => '1467656', 'url' => 'SR/Lamisil', 'image' => '', 'title' => 'Lamisil', 'tags' => array ( 0 => 'Lamisil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamisil', 'source_id' => 31149, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'antibiotik koji se koristi u lečenju gljivičnog oboljenja noktiju na prstima stopala', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845762, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamisil', 'Definition' => 'an antibiotic used to treat toenail fungus', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamisil', )

(object) array( 'id' => '1461320', 'url' => 'SR/market_positioning', 'image' => '', 'title' => 'pozocioniranje na tržištu', 'tags' => array ( 0 => 'pozocioniranje na tržištu', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'pozocioniranje na tržištu', 'source_id' => 57180, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225508', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pokušaj izdvajanja proizvoda od drugih konkurentskih sličnim njemu, stvarajući utisak o jedinstvenosti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967784910848, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'market positioning', 'Definition' => 'An attempt to distinguish a product from its similar competitors by creating a perception of uniqueness.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/18', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/18', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'market_positioning', )

(object) array( 'id' => '1467647', 'url' => 'SR/study_type', 'image' => '', 'title' => 'tip studje', 'tags' => array ( 0 => 'tip studje', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'tip studje', 'source_id' => 30943, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204525', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Primarne tehnike ispitivanja korišćene u protokolu observacije; tipovi su Svrha, Trajanje, Selekcija i Tajming', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999174033410, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'study type', 'Definition' => 'The primary investigative techniques used in an observational protocol; types are Purpose, Duration, Selection, and Timing.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'study_type', )

(object) array( 'id' => '1460602', 'url' => 'SR/modularization', 'image' => '', 'title' => 'modularizacija', 'tags' => array ( 0 => 'modularizacija', 1 => 'Education', 2 => 'Teaching', 3 => 'Teachnology', 4 => '', ), 'term' => 'modularizacija', 'source_id' => 712326, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Education', ), 'category' => array ( 0 => 'Teaching', ), 'company' => array ( 0 => 'Teachnology', ), 'lastedit' => '20110705082506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Obrazovni proces koji razdvaja materijal ili kurseva na module čime se studentima omogućava felksibilnost u izabirz modula priliko kreiranja programa studiranja.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964694757376, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'modularization', 'Company' => 'Teachnology', 'Definition' => 'Teaching process that splits material or courses into modules to allow students flexibility in selecting modules to create a program of study.', 'Domain' => 'Documentation', 'Industry' => 'Education', 'Part of Speech' => 'noun', 'Product Category' => 'Teaching', 'Usage Status' => 'New', 'Creation User' => 'katesd', 'Creation Date' => '2011/2/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'modularization', )

(object) array( 'id' => '1461315', 'url' => 'SR/bills_of_exchange', 'image' => '', 'title' => 'menica', 'tags' => array ( 0 => 'menica', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'menica', 'source_id' => 54540, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705224505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Pismena nalog od trasanta kojim se zahteva da trasat izvrši plaćanje fiksnog iznosa na zahtev, ili unapred određenog datuma u budućnosi.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862274, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'bills of exchange', 'Definition' => 'A written order from the drawer requiring the drawee to pay on demand, or at a preset future date, a fixed amount.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'bills_of_exchange', )